SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Integra Lifesciences Holdings Corp (IART)

NASDAQ: IART · Real-Time Price · USD
13.05+0.05 (+0.38%)
 
Market Cap1.01B-12.2%
Revenue (ttm)n/a
Net Incomen/a
EPSn/a
Shares Out77.77M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume103,941.106
Open12.86
Previous Close13.00
Day's Range12.82 - 13.21
52-Week Range8.70 - 20.49
Betan/a
AnalystsHold
Price Target19.40(+48.66%)
Earnings Daten/a
+0.54% (1D)
No price history available.
Insider Score
––Not scored
IART Insider Score

Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

About IART

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Address
1100 Campus Road, Princeton, NJ, 08540, United States
Market Cap
1.01 billion
Employees
4,427
Industrial Classification
Medical Devices

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$102.15K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

1 Day
+0.06%
5 Days
-19.15%
1 Month
-19.95%
6 Months
+32.33%
1 Year
-12.17%

$IART stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of IART by members of U.S. Congress

PoliticianTypeTraded
Gilbert CisnerosHouse / DPurchase$1.00K – $15.00KMar 10, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KMar 10, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KMar 9, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KFeb 10, 2020
Gilbert CisnerosHouse / DPurchase$1.00K – $15.00KFeb 10, 2020
Gilbert Ray CisnerosHouse / DPurchase$1.00K – $15.00KFeb 9, 2020

Recently reported changes in IART holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by IART's directors and management

Net Shares Purchased by Insiders−9k−5k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

IART Estimated quarterly lobbying spending

Source: U.S. Senate LDA

IART Revenue by Segment or Geography

$418.76MTotal
SegmentRevenue% of All
Specialty Surgery$309.27M73.85%
Tissue Reconstruction$109.49M26.15%

As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New IART patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to IART from public contracts

Source: USAspending.gov

IART Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for IART yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from IART’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

Buys
1
Sells
0
Buy Value
$102.15K
Distinct Buyers
1

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.